Geiger v. Pfizer, Inc.

271 F.R.D. 577, 2010 U.S. Dist. LEXIS 136256, 2010 WL 5147212
CourtDistrict Court, S.D. Ohio
DecidedDecember 13, 2010
DocketCivil Action No. 2:10-cv-0106
StatusPublished
Cited by13 cases

This text of 271 F.R.D. 577 (Geiger v. Pfizer, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Geiger v. Pfizer, Inc., 271 F.R.D. 577, 2010 U.S. Dist. LEXIS 136256, 2010 WL 5147212 (S.D. Ohio 2010).

Opinion

ORDER

ELIZABETH A. PRESTON DEAVERS, United States Magistrate Judge.

This case arises under the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1001 et seq. (“ERISA”). Plaintiff, Chris A. Geiger, brings this action against Defendants CIGNA Group Insurance (“CIG-NA”), Pfizer, Inc., Pfizer, Inc. Long-Term Disability Plan, and CIGNA Life Insurance Company of New York (“CLINCY”), asserting a claim under ERISA for long-term disability benefits under 29 U.S.C. § 1132(a)(1)(B). This matter is before the Court for consideration of Plaintiffs Motion to Conduct Limited Discovery (ECF No. 11), Defendants’ Opposition to Plaintiffs Motion (ECF No. 12), Plaintiffs Reply (ECF No. 18), Defendants’ Motion to File Sur-Reply Opposing Plaintiffs Motion to Conduct Limited Discovery (ECF No. 19), and Plaintiffs Memorandum in Opposition to Defendant’s Motion to File Sur-Reply (ECF No. 21). For the reasons that follow, the Court GRANTS IN PART AND DENIES IN PART Plaintiffs Motion to Conduct Limited Discovery as set forth herein and GRANTS Defendants’ Motion to File Sur-Reply.

I.

In its Motion to Conduct Limited Discovery, Plaintiff asserts that CLINCY1 operates under a conflict of interest because it acts as both the administrator determining eligibility for benefits and the insurer responsible for paying the benefits out of its own pocket. Plaintiff seeks limited discovery to depose Erie Poliziani, CLINCY’s Disability Claim Manager, in order to obtain information regarding CLINCY’s decision-making process when it reviews a claim for benefits. Plaintiff seeks this discovery for the limited purpose of determining the role that CLINCY’s conflict of interest and bias played in its decision to discontinue her long-term disability benefits and deny her benefits claim. Plaintiff represents that her allegations of conflict and bias are based in part upon: CLINCY’s discontinuation of her benefits despite the fact that there had been no change in any of her treating physician’s medical opinions or diagnoses; the inconsistent rationales CLINCY offered for discontinuing her benefits; and the fact that CLINCY denied her appeal just one day after she submitted additional information for CLINCY to consider. Plaintiff submits that the foregoing circumstances and allegations support her request to conduct limited discovery.

In their Response to Plaintiffs Motion, Defendants resist discovery, asserting that Plaintiff has failed to make the requisite [580]*580“initial good-canse showing for such discov-ery____” (Defs.’ Opp. 3, ECF No. 12. (citing Geer v. Hartford Life & Accident Ins. Co., No. 08-12837, 2009 WL 1620402 (E.D.Mich. June 9, 2009)).) In addition, Defendants assert that the discovery Plaintiff seeks is irrelevant and too broad. More specifically, Defendants contend that Plaintiff should not be permitted to depose Mr. Poliziani because a CLINCY Appeals Case Manager subsequently reviewed Plaintiffs complete file without deference to the prior reviews that Mr. Poliziani conducted.

Responding to Defendant’s reliance on Geer, Plaintiff counters that she has made a good-cause initial showing that probative evidence of bias would likely be developed though discovery. In addition to the circumstances and allegations she asserted in her Motion to Conduct Limited Discovery, Plaintiff adds that she also bases her allegations of conflict and bias in part on a California market study on the claim practices of the Life Insurance Company of North America (“LINA”).2 Plaintiff attached a copy of the Public Report of the Targeted Market Conduct Examination of the Claims of the Life Insurance Company of North America NAIC #65498 CDI #1513-1 (“LINA Market Study”) as an exhibit to her Reply. Plaintiff references the study’s finding that of 224 claims files examined, the examiners identified 57 claim-handling violations. She notes that LINA acknowledged wrongdoing, paid a penalty, and re-evaluated thousands of previously denied claims as a result of this study. Finally, Plaintiff highlights the specific findings of wrongdoing, two of which Plaintiff maintains CLINCY engaged in here. Specifically, Plaintiff asserts that CLINCY used snippets of information from a physician who found her to be disabled to support its finding that she is not disabled without seeking clarification from that physician. Plaintiff also asserts that CLINCY denied her claims without performing any analysis of her transferable skills or of the labor market to identify alternate occupations she could perform. Instead, Plaintiff asserts that Defendant simply found that she was qualified for a “Light Work” occupation as that term is defined in the U.S. Department of Labor Description Occupational Titles 262.157-010, even though the record contains no substantive analysis concerning alternate positions Plaintiff could perform. Plaintiff points out that in Geer, the case upon which Defendants rely, the court found that limited discovery into the conflict of interest issue was appropriate based upon the results of a similar California market study. (See Pl.’s Reply 6 (citing Geer, 2009 WL 1620402 at *6).)

On September 16, 2010, Defendants moved to file a sur-reply, asserting that because Plaintiff raised the LINA Market Study for the first time in her Reply, that it is fair, equitable, and reasonable for Defendants to have an opportunity to address it. In their Sur-Reply (ECF No. 19), Defendants assert that the LINA Market Study is irrelevant due to its timing, its focus on LINA and California law, and the corrective actions LINA took in response to the study.

On September 29, 2010, Plaintiff filed a Memorandum in Opposition to Defendants’ Motion to File Sur-Reply (ECF No. 21). Plaintiff contends that Defendants’ Motion should be denied because her references to the LINA Market Study were in direct response to the case law Defendants cited in their Memorandum in Opposition.

II.

A. Motion to File Sur-Reply

As a preliminary matter, the Court GRANTS Defendants’ Motion to File SurReply (ECF No. 19). Southern District of Ohio Local Civil Rule 7.2(a)(2) permits the filing of a motion and memorandum in support, a memorandum in opposition, and a reply memorandum. The Rule further states that “[n]o additional memoranda beyond those enumerated will be permitted except upon leave of court for good cause shown.” S.D. Ohio Civ. R. 7.2(a)(2). This Court has routinely found good cause exists to permit a party to file a sur-reply to address an issue raised for the first time in a reply brief. See

[581]*581e.g., Thompson v. Transam Trucking, Inc., 750 F.Supp.2d 871, 884, No. 2:08-CV-927, 2010 WL 4384234, at *10 (S.D.Ohio Oct. 21, 2010); Levy v. Cain, Watters & Associates, P.L.L.C., No. 2:09-cv-723, 2010 WL 271300, at *2 (S.D.Ohio Jan. 15, 2010). Here, the Court agrees with Defendants, that Plaintiff raised the LINA Market Study as a basis for conducting discovery for the first time in her Reply. Consequently, the Court finds that Defendants have demonstrated good cause for filing an additional memorandum to address the study. Accordingly, Defendants’ Motion is GRANTED. The Court, therefore, considers the Sur-Reply.

B. Motion to Conduct Limited Discovery

1.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
271 F.R.D. 577, 2010 U.S. Dist. LEXIS 136256, 2010 WL 5147212, Counsel Stack Legal Research, https://law.counselstack.com/opinion/geiger-v-pfizer-inc-ohsd-2010.